Robert Toth

ROBERT TOTH, JR. is a Senior Analyst with the Prudential Vector
Healthcare Group, covering biotechnology companies focusing on cancer
therapeutics, genomic platforms, and neuroscience applications. He
joined Prudential Securities via the July 1999 acquisition of Vector
Securities International, Inc. Prior to joining Vector, Mr. Toth served
as Business Development Analyst with the biotechnology company
Connectics Corp. He received his BBA in Biology and Biochemistry from
California State Polytechnic University, and an MBA from the University
of Washington School of Business.